---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-027758"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2023-06-13T23:59:59+00:00"
generated_at: "2026-06-14T02:05:39.606685+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Treace Medical completes $20M acquisition of RedPoint Medical3D's PSI assets

## Summary
- Paid $20M cash at closing for RPM-3D assets used in pre-op planning and patient-specific guides for bunion surgery.
- Earnout up to $10M: $3.5M for transition services, $3.5M for tech milestones, up to $3M upon patent issuance.
- RPM-3D software integration with Lapiplasty system planned for 2023; commercial launch expected H2 2024.
- CEO says acquisition adds FDA-cleared PSI technologies, expanding customization for Lapiplasty and Adductoplasty.
- Entered non-compete/non-solicitation agreements with RPM-3D and consulting agreements with Dr. Adam Perler and James Spitler.

## SEC filing metadata
- accession: 0000950170-23-027758
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2023-06-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000095017023027758/0000950170-23-027758-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000095017023027758/tmci-20230612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-027758
- JSON: https://secwatch.observer/filing/0000950170-23-027758.json
- Plain text: https://secwatch.observer/filing/0000950170-23-027758.txt

## Key facts
- M&A Transactions
  TREACE MEDICAL CONCEPTS, INC. completed an acquisition involving MIOS Marketing, LLC d/b/a RedPoint Medical3d ("RPM-3D") for $20.0 million (closed 2023-06-12).
  - Action: acquisition
  - Counterparty: MIOS Marketing, LLC d/b/a RedPoint Medical3d ("RPM-3D")
  - Consideration: $20.0 million
  - Closing: 2023-06-12
  source text: of RPM-3D. On June 12, 2023, the Company completed its acquisition of certain assets of RPM-3D pursuant to the APA. In accordance with the APA, at closing, TMCI paid RPM-3D $20.0 million in exchange for RPM-3D’s assets used in providing pre-operative planning and patient-specific guides for the surgical correction of foot and ankle deformities. Under the APA,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000095017023027758/0000950170-23-027758-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.